A generation that thinks and feels differently Gen Z is the first generation to enter medicine as digital natives, but their ...

Kymera Therapeutics has announced positive results from its trial of KT-621 to treat patients with moderate to severe atopic ...

Lilly has announced plans to build a $6bn facility in Alabama in the US for the manufacture of active pharmaceutical ...

The US FDA has announced the launch of the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices ...

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and ...

Our Nature Custom Media team recently took on an ambitious project: producing a video that spanned two continents, covered a ...

Novo Nordisk has presented new findings from its phase 3 Evoke and Evoke+ trials on using semaglutide as part of Alzheimer’s ...

Eli Lilly has appointed Carolyn Bertozzi to its Board of Directors as a returning member, after she served on Lilly’s board ...

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and ...

The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial ...

New results from the phase 1 VNA-318-01 human study have shown favourable safety and tolerability, with the data showing that ...

Kite, a Gilead Company, has presented new findings demonstrating the safety, efficacy and quality of life benefits offered by ...